Osimertinib-d6 - HY-15772S
Nur noch %1 verfügbar
Catalog #
HY-15772S
Ab
506,00 €
Osimertinib-d6 is a deuterium labeled osimertinib. Osimertinib is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-15772S/Osimertinib-d6-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-Kinase/protease |
| Alternative Names | AZD-9291-d6; Mereletinib-d6 |
| CAS | 1638281-44-3 |
| Storage | 4°C (Powder, protect from light, stored under nitrogen) |
| MWT | 505.64 |
| Solubility | DMSO : 125mg/mL (ultrasonic;warming;heat to 60°C) |
| Clinical Information | No Development Reported |
| Target | EGFR |
| Application: | Cancer-Kinase/protease |
|---|